Journal Mobile Options
Table of Contents
Vol. 81, No. 4, 2012
Issue release date: June 2012
Psychother Psychosom 2012;81:250–252
(DOI:10.1159/000335821)

Neurocognitive Training in Patients with Bipolar Disorders: Current Status and Perspectives

Fuentes-Durá I. · Balanzá-Martínez V. · Ruiz-Ruiz J.C. · Martínez-Arán A. · Girón M. · Solé B. · Sánchez-Moreno J. · Gómez-Beneyto M. · Vieta E. · Tabarés-Seisdedos R.
aDepartment of Personality, Assessment and Psychological Treatments, University of Valencia, bDepartment of Medicine, University of Valencia, CIBERSAM, and cDepartment of Methodology of Behavioral Science, University of Valencia, Valencia, dBipolar Disorders Programme, Institute of Clinical Neuroscience, August Pi i Sunyer Biomedical Research Institute, University of Barcelona, CIBERSAM, Barcelona, and eDepartment of Clinical Medicine, University Miguel Hernandez, Alicante, Spain

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


First-Page Preview
Abstract of Letter to the Editor

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Rosa AR, Reinares M, Franco C, Comes M, Torrent C, Sanchez-Moreno J, Martínez-Arán A, Salamero M, Kapczinski F, Vieta E: Clinical predictors of functional outcome of bipolar patients in remission. Bipolar Disord 2009;11:401–409.

    External Resources

  2. Martinez-Arán A, Vieta E, Colom F, Torrent C, Sanchez-Moreno J, Reinares M, Benabarre A, Goikolea JM, Bruge E, Daban C, Salamero M: Cognitive impairment in euthymic bipolar patients, implications for clinical and functional outcome. Bipolar Disord 2004;6:224–232.
  3. Balanzá-Martínez V, Tabarés-Seisdedos R, Selva-Vera G, Martínez-Arán A, Torrent C, Salazar-Faile J, Leal-Cercos C, Vieta E, Gomez-Beneito M: Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study. Psychother Psychosom 2005;74:113–119.
  4. Torres IJ, Boudreau VG, Yatham LN: Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand 2007;116(suppl 434):17–26.

    External Resources

  5. Mur M, Portella MJ, Martínez-Arán A, Pifarré J, Vieta E: Persistent neuropsychological deficit in euthymic bipolar patients: executive function as a core deficit. J Clin Psychiatry 2007;68:1078–1086.
  6. Wingo AP, Harvey PD, Baldessarini RJ: Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord 2009;11:113–125.
  7. Tohen M, Hennen J, Zarate CM Jr, Baldessarini RJ, Strakowski SM, Stoll AL, Faedda GL, Suppes T, Gebre-Medhin P, Cohen BM: Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 2000;157:220–228.
  8. Martínez-Arán A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, Malhi GS, Gonzaléz-Pinto A, Daba C, Alvarez-Grandi S, Fountoulakis K, Kaprinis G, Tabarés-Seisdedos R, Ayuso-Mateos JL: Functional outcome in bipolar disorders: the role of clinical and cognitive factors. Bipolar Disord 2007;9:103–113.
  9. Sanchez-Moreno J, Martinez-Aran A, Tabarés-Seisdedos R, Torrent C, Vieta E, Ayuso-Mateos JL: Functioning and disability in bipolar disorders: an extensive review. Psychother Psychosom 2009;78:285–297.
  10. Martino DJ, Marengo E, Igoa A, Scapola M, Ais ED, Perinot L, Strejilevich SE: Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: a prospective 1-year follow-up study. J Affect Disord 2009;116:37–42.
  11. Tabarés-Seisdedos R, Balanzá-Martínez V, Sánchez-Moreno J, Martinez-Aran A, Salazar-Fraile J, Selva-Vera G, Rubio C, Mata I, Gómez-Beneyto M, Vieta E: Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J Affect Disord 2008;109:286–299.
  12. Jaeger J, Vieta E: Functional outcome and disability in bipolar disorders: ongoing research and future directions. Bipolar Disord 2007;9:1–2.
  13. Jaeger J, Berns S, Loftus S, Gonzalez C, Zobor P: Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. Bipolar Disord 2007;9:93–102.
  14. Bonnín CM, Martínez-Arán A, Torrent C, Pacchiarotti I, Rosa AR, Franco C, Murru A, Sanchez-Moreno J, Vieta E: Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord 2010;121:156–160.
  15. Green MF: Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 2006;67:e12.

    External Resources

  16. Twamley EW, Jeste DV, Bellack AS: A review of cognitive training in schizophrenia. Schizophr Bull 2003;2:359–382.

    External Resources

  17. Zarate CA, Tohen M, Land M, Cavanagh S: Functional impairment and cognition in bipolar disorder. Psychiatr Q 2000;71:309–329.
  18. Solé B, Bonnin CM, Torrent C, Balanzá-Martínez V, Tabarés-Seisdedos R, Popovic D, Martínez-Arán A, Vieta E: Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Acta Psychiatr Scand, in press.
  19. McGurk SR, Mueser KT, Pascaris A: Cognitive training and supported employment for persons with severe mental Illness: one-year results from a randomised controlled trial. Schizophr Bull 2005;31:898–909.

    External Resources

  20. Choi J, Medalia M: Factors associated with a positive response to cognitive remediation in a community psychiatric sample. Psychiatric Serv 2005;56:602–604.
  21. Harvey PD, Wingo AP, Burdick KE, Baldessarini RJ: Cognition and disability in bipolar disorder: lessons from schizophrenia research. Bipolar Disord 2010;12:364–375.

    External Resources

  22. Glahn DC, Barrett J, Bearden CE, Mintz J, Green MF, Monkul ES, Najt P, Soares JC, Velligan DI: Dissociable mechanisms for memory impairment in bipolar disorder and schizophrenia. Psychol Med 2006;36:1085–1095.

    External Resources

  23. Brissos S, Videira V, Kapczinski F: Cognitive performance and quality of life in bipolar disorder. Can J Psychiatry 2008;53:517–524.

    External Resources

  24. Rozenthal M, Laks J, Engelhardt E: Neuropsychological aspects of depression. Rev Psiquiatria Rio Grande Sul 2004;26:204–212.
  25. Burdick KE, Braga RJ, Goldberg JF, Malhotra AK: Cognitive dysfunction in bipolar disorder. Future place of pharmacotherapy. CNS Drugs 2007;21:971–981.
  26. Tufrey K, Coulston C: Cognitive remediation for bipolar disorder: adapting from models used in schizophrenia and acquired brain injury. Acta Neuropsiquiatr 2010;22:311–313.

    External Resources

  27. Martínez-Arán A, Vieta E, Reinares M, Colom F, Torrent C, Sanchez-Moreno J, Benabarre A, Goikolea JM, Comes M, Salamero M: Cognitive functions across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004;161:262–270.
  28. Goodwin GM, Martínez-Arán A, Glahn DC, Vieta E: Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. Eur Neuropsychopharmacol 2008;18:787–793.
  29. Leifker F R, Patterson T L, Bowie CR, Mausbach BT, Harvey PD: Psychometric properties of performance-based functional capacity: test-retest reliability, practice effects, and potential sensitivity to change. Schizophr Res 2010;119:246–252.

    External Resources

  30. Rocca C, Lafer B: Alterações neuropsicológicas no transtorno bipolar. Rev Bras Psiquiatr 2006;28:226–237.

    External Resources

  31. Schwalbe E, Medalia A: Cognitive dysfunction and competency restoration: using cognitive remediation to help restore the unrestorable. J Am Acad Psychiatry Law 2007;35:518–525.
  32. Medalia A, Dom H, Watras-Gans S: Treating problem-solving deficits on acute care psychiatric inpatient unit. Psychiatry Res 2000;97:79–88.
  33. McGurk SR, Schiano D, Mueser KT, Wolfe R: Implementation of the thinking skills for program in a psychosocial clubhouse. Psychiatr Rehabil J 2010;33:190–199.

    External Resources

  34. Deckersbach T, Nierenberg AA, Kessler R, Lund HG, Ametrano RM, Sachs G, Rauch SL, Dougherty D: Cognitive rehabilitation for bipolar disorders: an open trial for employed patients with residual depressive symptoms. CNS Neurosci Ther 2010;16:298–307.

    External Resources

  35. Daban C, Martinez-Aran A, Torrent C, Tabarés-Seisdedos, Balanzá-Martínez V, Salazar-Fraile, Selva-Vera G, Vieta E: Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review. Psychother Psychosom 2006;75:72–84.
  36. Barch DM: Neuropsychological abnormalities in schizophrenia and major mood disorders: similarities and differences. Curr Psychiatry Rep 2009;11:313–319.

    External Resources

  37. Solé B, Martínez-Arán A, Torrent C, Bonnin CM, Reinares M, Popovic D, Sánchez-Moreno J, Vieta E: Are bipolar II patients cognitively impaired? A systematic review. Psychol Med 2011;41:1791–1803.
  38. Müller D, Roder V: Integrated psychological therapy and integrated neurocognitive therapy; in Roder V, Medalia A (eds): Neurocognition and Social Cognition in Schizophrenia Patients. Basel, Karger, 2010, pp 118–144.
  39. Medalia S, Mambrino E: An overview of the neuropsychological and neurological approach to remediation; in Roder V, Medalia A (eds): Neurocognition and Social Cognition in Schizophrenia Patients. Basel, Karger, 2010, pp 104–117.
  40. Hogarty GE, Flesher S: Developmental theory for a cognitive enhancement therapy of schizophrenia. Schizophr Bull 1999;25:677–692.
  41. Hogarty GE, Flescher S, Ulrich R, Carter M, Green Wald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry L, Garrett A, Parepally H, Zoretich R: Cognitive enhancement therapy for schizophrenia. Arch Gen Psychiatry 2004;61:866–876.
  42. Martínez-Arán A, Torrent C, Solé B, Bonnín CM, Rosa AR, Sánchez-Moreno J, Vieta E: Functional remediation for bipolar disorder. Clin Pract Epidemiol Ment Health 2011;7:112–116.

    External Resources



Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00